药易购
(300937)
| 流通市值：20.04亿 | | | 总市值：30.47亿 |
| 流通股本：6291.82万 | | | 总股本：9566.67万 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,242,124,750.68 | 2,157,138,212.15 | 1,137,614,693.12 | 4,380,809,520.01 |
| 营业收入 | 3,242,124,750.68 | 2,157,138,212.15 | 1,137,614,693.12 | 4,380,809,520.01 |
| 二、营业总成本 | 3,215,835,561.02 | 2,136,963,938.03 | 1,120,320,821.96 | 4,346,174,702.44 |
| 营业成本 | 2,884,224,490.97 | 1,923,742,125.35 | 1,011,930,212.47 | 3,990,533,313.19 |
| 税金及附加 | 6,427,720.7 | 4,399,057.78 | 2,245,916.74 | 8,866,486.16 |
| 销售费用 | 257,750,651.18 | 164,102,280.13 | 84,234,538.85 | 251,435,378.16 |
| 管理费用 | 52,007,950.24 | 34,477,443.11 | 16,560,922.61 | 70,980,183.23 |
| 研发费用 | 8,177,056.7 | 5,619,039.06 | 2,770,134.22 | 15,467,329.87 |
| 财务费用 | 7,247,691.23 | 4,623,992.6 | 2,579,097.07 | 8,892,011.83 |
| 其中:利息费用 | 6,245,323.06 | 4,519,758.88 | 2,470,053.97 | 9,710,490.08 |
| 其中:利息收入 | 2,605,554.65 | 1,435,151.29 | 653,293.93 | 3,872,883.43 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 937,267.79 | 622,828.29 | 441,202.7 | -1,835,026.32 |
| 资产处置收益 | 162,165.11 | 121,117.81 | -1,927.82 | -606,269.06 |
| 资产减值损失(新) | -6,710,869.07 | -6,409,931.62 | -1,764,225.83 | -9,929,815.75 |
| 信用减值损失(新) | -18,085,506.5 | -12,660,591.75 | -10,352,278.65 | -7,896,914.22 |
| 其他收益 | 1,430,965.05 | 591,811.03 | 335,999.59 | 2,012,202.99 |
| 四、营业利润 | 4,023,212.04 | 2,439,507.88 | 5,952,641.15 | 16,378,995.21 |
| 加:营业外收入 | 224,117.9 | 237,746.31 | 109,027.77 | 2,103,695.06 |
| 减:营业外支出 | 662,435.98 | 268,919.29 | 176,314.79 | 1,305,960.79 |
| 五、利润总额 | 3,584,893.96 | 2,408,334.9 | 5,885,354.13 | 17,176,729.48 |
| 减:所得税费用 | 11,790,037.47 | 11,473,266.97 | 1,641,829.3 | 1,776,820.86 |
| 六、净利润 | -8,205,143.51 | -9,064,932.07 | 4,243,524.83 | 15,399,908.62 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -8,205,143.51 | -9,064,932.07 | 4,243,524.83 | 15,399,908.62 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -8,356,461.16 | -7,614,393.65 | 4,183,729.42 | 16,358,248.01 |
| 少数股东损益 | 151,317.65 | -1,450,538.42 | 59,795.41 | -958,339.39 |
| 扣除非经常损益后的净利润 | -10,152,605.74 | -8,323,130.54 | 3,564,041.22 | 12,369,745.76 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.09 | -0.08 | 0.04 | 0.17 |
| (二)稀释每股收益 | -0.09 | -0.08 | 0.04 | 0.17 |
| 九、综合收益总额 | -8,205,143.51 | -9,064,932.07 | 4,243,524.83 | 15,399,908.62 |
| 归属于母公司股东的综合收益总额 | -8,356,461.16 | -7,614,393.65 | 4,183,729.42 | 16,358,248.01 |
| 归属于少数股东的综合收益总额 | 151,317.65 | -1,450,538.42 | 59,795.41 | -958,339.39 |
| 公告日期 | 2025-10-24 | 2025-08-12 | 2025-04-25 | 2025-04-11 |
| 审计意见(境内) | | | | 标准无保留意见 |